|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2008.18.6965 on January 21 2009 © 2009 American Society of Clinical Oncology. Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast CancerFrom the Geneva Cancer Registry, Institute for Social and Preventive Medicine, Geneva University; Senology and Surgical Gynecologic Oncology Unit, Department of Gynecology and Obstetrics, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Universitair Ziekenhuis Brussel, Jette, Belgium; and Department of Community Occupational and Family Medicine, National University of Singapore, Singapore. Corresponding author: Vincent Vinh-Hung, MD, PhD, Oncology Center, Universitair Ziekenhuis Brussel, 101 Laarbeeklaan, 1090 Jette, Belgium; e-mail: conrvhgv{at}uzbrussel.be. Purpose In the current pTNM classification system, nodal status of breast cancer is based on the number of involved lymph nodes and does not account for the total number of lymph nodes removed. In this study, we assessed the prognostic value of the lymph node ratio (LNR; ie, ratio of positive over excised lymph nodes) as compared with pN staging and determined its optimal cutoff points. Patients and Methods From the Geneva Cancer Registry, we identified all women diagnosed with node-positive breast cancer between 1980 and 2004 (n = 1,829). The prognostic value of LNRs was calculated for values ranging from 0.05 to 0.95 by Cox regression analysis and validated by bootstrapping. Based on maximum likelihood, we identified cutoff points classifying women into low-, intermediate-, and high-risk LNR groups.
Results Optimal cutoff points classified patients into low- ( Conclusion LNR predicts survival after breast cancer more accurately than pN classification and should be considered as an alternative to pN staging. Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|